SCHEMBL25919042

SCHEMBL25919042

Cc1cccc(C)c1-n1c2ccccc2n2c(C)[n+](N)cc12

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19233780 0.72 TDP1 (0.34) TDP1
SCHEMBL19233781 0.72 EPHB4 (0.35) TDP1
SCHEMBL19234007 0.68 CRHR1 (0.40)
SCHEMBL19234176 0.64 EPHB4 (0.36)
SCHEMBL2958307 0.63 ALKBH5 (0.53)
SCHEMBL19233704 0.60 CD44 (0.34) TDP1
SCHEMBL19233782 0.58 DPP4 (0.36) TDP1
SCHEMBL21226862 0.58 ALKBH5 (0.47) TDP1
SCHEMBL623218 0.55 TDP1 (0.55) TDP1
SCHEMBL29306729 0.53 ALKBH5 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11716898-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11716898-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, JUND TDP1 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.